An investigation is underway following fresh claims of sexual abuse perpetrated by international forces in the Central African Republic. In…
News analysis The latest battle between the Obama Administration and Congress is a confusing one focused, nominally at least, on…
Leading humanitarian organizations like the ONE Campaign and Oxfam appear to strongly disagree on whether to support the Obama Administration’s…
For today’s Humanosphere podcast, we’re talking with Gilles van Cutsem, a physician and Medical Director for Médecins Sans Frontières /…
New York and New Jersey do not see eye to eye with the federal government when it comes to preventing…
Discussions are currently underway to bring to an end the year-long strife and fighting that has beset the Central African…
Activists say there’s no question that the HPV vaccine is desperately needed in poor countries and that this will be a big life-saver for women. But the vaccine is still too expensive for the poorest countries, where the per capita spending on health care can be as low as $10 or $20 per capita.
The Indian Supreme Court has rejected a drug patent application by the international pharmaceutical firm Novartis, an event that merited coverage by the New York Times, BBC and many other media – news which you might think is mostly a matter for the business page or drug industry insiders. In fact, the case may represent one of the most difficult dilemmas in global health. It is a fight that is far from over.
Flickr, Brooks Elliott One of the biggest, thorniest dilemmas in global health is coming to a head in India. (And…
The global health strategy to expand childhood immunizations, largely backed by the Bill & Melinda Gates Foundation, is too focused…